A rare CHD5 haplotype and its interactions with environmental factors predicting hepatocellular carcinoma risk
- PMID: 29907144
- PMCID: PMC6003142
- DOI: 10.1186/s12885-018-4551-y
A rare CHD5 haplotype and its interactions with environmental factors predicting hepatocellular carcinoma risk
Abstract
Background: CHD5 is a conventional tumour-suppressing gene in many tumours. The aim of this study was to determine whether CHD5 variants contribute to the risk of hepatocellular carcinoma (HCC).
Methods: Gene variants were identified using next-generation sequencing targeted on referenced mutations followed by TaqMan genotyping in two case-control studies.
Results: We discovered a rare variant (haplotype AG) in CHD5 (rs12564469-rs9434711) that was markedly associated with the risk of HCC in a Chinese population. A logistical regression model and permutation test confirmed the association. Indeed, the association quality increased in a gene dose-dependent manner as the number of samples increased. In the stratified analysis, this haplotype risk effect was statistically significant in a subgroup of alcohol drinkers. The false-positive report probability and multifactor dimensionality reduction further supported the finding.
Conclusions: Our results suggest that the rare CHD5 gene haplotype and alcohol intake contribute to the risk of HCC. Our findings can be valuable to researchers of cancer precision medicine looking to improve diagnosis and treatment of HCC.
Keywords: Alcohol intake; CHD5; Gene haplotype; Hepatocellular carcinoma; Risk.
Conflict of interest statement
Ethics approval and consent to participate
The ethics committee of Guangdong Medical University authorised the experimental and research protocols of this study. All procedures performed in studies were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. All controls and and patients (or relatives of patients who already died) provided written informed consent.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures

Similar articles
-
CHD5 a tumour suppressor is epigenetically silenced in hepatocellular carcinoma.Liver Int. 2014 Jul;34(6):e151-60. doi: 10.1111/liv.12503. Epub 2014 Mar 15. Liver Int. 2014. PMID: 24529164
-
Effects of interactions between environmental factors and KIF1B genetic variants on the risk of hepatocellular carcinoma in a Chinese cohort.World J Gastroenterol. 2016 Apr 28;22(16):4183-90. doi: 10.3748/wjg.v22.i16.4183. World J Gastroenterol. 2016. PMID: 27122668 Free PMC article.
-
The single-nucleotide polymorphisms in CHD5 affect the prognosis of patients with hepatocellular carcinoma.Oncotarget. 2017 Dec 26;9(17):13222-13230. doi: 10.18632/oncotarget.23812. eCollection 2018 Mar 2. Oncotarget. 2017. PMID: 29568352 Free PMC article.
-
Haplotype-based case-control study of DNA repair gene XRCC3 and hepatocellular carcinoma risk in a Chinese population.Tumour Biol. 2014 Apr;35(4):3415-9. doi: 10.1007/s13277-013-1451-2. Epub 2013 Dec 5. Tumour Biol. 2014. PMID: 24307625
-
PNPLA3 rs738409 is not associated with the risk of hepatocellular carcinoma and persistent infection of hepatitis B virus (HBV) in HBV-related subjects: A case-control study and meta-analysis on Asians.Gene. 2020 Jun 5;742:144585. doi: 10.1016/j.gene.2020.144585. Epub 2020 Mar 13. Gene. 2020. PMID: 32173542
Cited by
-
Pathway analysis of smoking-induced changes in buccal mucosal gene expression.Egypt J Med Hum Genet. 2022;23(1):69. doi: 10.1186/s43042-022-00268-y. Epub 2022 Mar 17. Egypt J Med Hum Genet. 2022. PMID: 37521848 Free PMC article.
-
Pan-Cancer Analysis Identifies CHD5 as a Potential Biomarker for Glioma.Int J Mol Sci. 2022 Jul 30;23(15):8489. doi: 10.3390/ijms23158489. Int J Mol Sci. 2022. PMID: 35955624 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical